[1]
“The High Resolution MASS spectrometry in Personalised Medicine: Retinol-Binding Protein 4 as a Candidate Biomarker Predictor of Progression in Bladder Urothelial Carcinoma”, aup, vol. 38, no. 1-2, pp. 12–17, Jan. 2024, doi: 10.24915/aup.156.